KISS1 and breast cancer: The kisspeptin 1 receptor is highly expressed in patients with triple-negative BC; this receptor is involved in the malignant transformation of BC epithelial cells, and a higher level of kisspeptin has been observed in patients with triple-negative BC than in healthy individuals [116].